At a glance
Multidrug-resistant organisms (MDROs) are continuing to develop and spread in healthcare settings throughout the United States. Because of this, efforts to prevent MDRO transmission are still needed. In the past, MDROs were identified after lab confirmation, however, research has found that these organisms can spread long before being detected. A prevention approach that incorporates multiple healthcare facilities can potentially limit spread more effectively than response strategies alone.
Overview
CDC has developed two guides and FAQs for healthcare facilities, state, local, and territorial health departments to limit the spread of novel or targeted (e.g., Candida auris, carbapenemase-producing CRE) MDROs, FAQs, and a graphic (Figure 1) showing the relationship between prevention and response activities.
Comparison of strategies
MDRO Guide
Technical appendix
Implementing Regional MDROs Prevention Bundles ─ Mathematical Modeling Methods and Findings
Lab resources
Antimicrobial Resistance Laboratory Network
Investigation guides and infection control assessments
Transmission-Based Precautions
Candida auris Infection Prevention
Considerations for Reducing Risk: Water in Healthcare Facilities
Colonization screenings
Antimicrobial Resistance Laboratory Networks
About Carbapenem-resistant Enterobacterales
Inter-facility transfer form
Inter-Facility Infection Control Transfer Form for States Establishing HAI Prevention Collaboratives
MDRO resources
Candida auris General Information